| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Eyenovia Inc (NASDAQ: EYEN)
EYEN Technical Analysis
5
| As on 2nd Jul 2025 EYEN STOCK Price closed @ 15.82 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.87 & Strong Buy for SHORT-TERM with Stoploss of 1.64 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EYENSTOCK Price
| Open | 10.70 | Change | Price | % |
| High | 17.18 | 1 Day | 5.26 | 49.81 |
| Low | 10.70 | 1 Week | 10.34 | 188.69 |
| Close | 15.82 | 1 Month | 14.69 | 1300.00 |
| Volume | 4631749 | 1 Year | 14.22 | 888.75 |
| 52 Week High 10.88 | 52 Week Low 0.03 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| OPEN | 3.17 | 4.28% |
| INTC | 24.56 | 2.93% |
| PGEN | 2.94 | 58.92% |
| NVDA | 180.45 | -0.86% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
| PPSI | 4.35 | 39.87% |
| TLRY | 1.03 | -12.71% |
| CODX | 0.29 | 7.41% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| EYEN Daily Charts |
EYEN Intraday Charts |
Whats New @ Bazaartrend |
EYEN Free Analysis |
|
|
EYEN Important Levels Intraday
| RESISTANCE | 28.31 |
| RESISTANCE | 24.30 |
| RESISTANCE | 21.83 |
| RESISTANCE | 19.35 |
| SUPPORT | 12.29 |
| SUPPORT | 9.81 |
| SUPPORT | 7.34 |
| SUPPORT | 3.33 |
EYEN Forecast August 2025
| 4th UP Forecast | 18.59 |
| 3rd UP Forecast | 17.7 |
| 2nd UP Forecast | 17.15 |
| 1st UP Forecast | 16.6 |
| 1st DOWN Forecast | 15.04 |
| 2nd DOWN Forecast | 14.49 |
| 3rd DOWN Forecast | 13.94 |
| 4th DOWN Forecast | 13.05 |
EYEN Weekly Forecast
| 4th UP Forecast | 16.88 |
| 3rd UP Forecast | 16.54 |
| 2nd UP Forecast | 16.33 |
| 1st UP Forecast | 16.12 |
| 1st DOWN Forecast | 15.52 |
| 2nd DOWN Forecast | 15.31 |
| 3rd DOWN Forecast | 15.10 |
| 4th DOWN Forecast | 14.76 |
EYEN Forecast2025
| 4th UP Forecast | 48.87 |
| 3rd UP Forecast | 38.27 |
| 2nd UP Forecast | 31.72 |
| 1st UP Forecast | 25.17 |
| 1st DOWN Forecast | 6.47 |
| 2nd DOWN Forecast | -0.08 |
| 3rd DOWN Forecast | -6.63 |
| 4th DOWN Forecast | -17.23 |
Eyenovia Inc ( NASDAQ USA Symbol : EYEN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
EYEN Business Profile
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print (MAP) platform technology. The company focuses on to develop clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. Its pipelines focus on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company's product candidates in pipeline include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York. Address: 295 Madison Avenue, New York, NY, United States, 10017
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service